Moody Aldrich Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,483
Closed -$282K 213
2024
Q3
$282K Sell
2,483
-293
-11% -$34.8K 0.05% 168
2024
Q2
$344K Sell
2,776
-2,984
-52% -$384K 0.07% 150
2024
Q1
$760K Sell
5,760
-1,929
-25% -$238K 0.13% 125
2023
Q4
$838K Sell
7,689
-495
-6% -$51.4K 0.15% 120
2023
Q3
$846K Buy
+8,184
New +$882K 0.16% 120
2021
Q2
Sell
-13,073
Closed -$962K 184
2021
Q1
$962K Buy
13,073
+4,957
+61% +$366K 0.14% 124
2020
Q4
$633K Hold
8,116
0.1% 130
2020
Q3
$642K Buy
+8,116
New +$636K 0.13% 116

Other funds holding MRK

Moody Aldrich Partners's MRK Position: Q4 2024 in Review

Moody Aldrich Partners sold out of Merck (MRK) in Q4 2024, closing a stake of 2,483 shares — an estimated $282K sold.

Moody Aldrich Partners first reported a position in MRK in Q3 2020 and held it in 8 quarters. The position peaked at $962K in Q1 2021. 3,607 funds tracked by Wall St. Rank hold MRK as of Q4 2024.

  • Moody Aldrich Partners reported no remaining Merck position as of Q4 2024 after selling out during the quarter.
  • Moody Aldrich Partners sold 2,483 Merck shares in Q4 2024, an estimated $282K.
  • Moody Aldrich Partners first reported a position in Merck in Q3 2020 and held it in 8 quarters.
  • Moody Aldrich Partners's Merck position peaked at $962K in Q1 2021.
  • 3,607 funds tracked by Wall St. Rank held Merck as of Q4 2024.

Based on Moody Aldrich Partners's 13F filing for Q4 2024, filed 23 Jan 2025.